0001213900-20-012825.txt : 20200518
0001213900-20-012825.hdr.sgml : 20200518
20200518162750
ACCESSION NUMBER: 0001213900-20-012825
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200515
FILED AS OF DATE: 20200518
DATE AS OF CHANGE: 20200518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dillione Janet
CENTRAL INDEX KEY: 0001489798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 20889916
MAIL ADDRESS:
STREET 1: ONE WAYSIDE ROAD
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 CONNELL DRIVE
STREET 2: SUITE 5000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 400 CONNELL DRIVE
STREET 2: SUITE 5000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
doc4.xml
PRIMARY DOCUMENT
X0306
4
2020-05-15
false
0001410098
CorMedix Inc.
CRMD
0001489798
Dillione Janet
C/O CORMEDIX INC.
400 CONNELL DRIVE, SUITE 5000
BERKELEY HEIGHTS
NJ
07922
true
false
false
false
Common Stock
53473.0000
D
Phantom Stock
0.0000
2020-05-15
4
A
false
5253.0000
0.0000
A
Common Stock
5253.0000
5253.0000
D
Stock Option (Right to Buy Common Stock)
5.6300
2030-02-25
Common Stock
15000.0000
15000.0000
D
Phantom Stock
0.0000
Common Stock
1706.0000
1706.0000
D
Phantom Stock
0.0000
Common Stock
2099.0000
2099.0000
D
Phantom Stock
0.0000
Common Stock
945.0000
945.0000
D
Phantom Stock
0.0000
Common Stock
1126.0000
1126.0000
D
Phantom Stock
0.0000
Common Stock
843.0000
843.0000
D
Stock Option (Right to Buy Common Stock)
8.3000
2029-01-10
Common Stock
15000.0000
15000.0000
D
Phantom Stock
0.0000
Common Stock
1328.0000
1328.0000
D
Phantom Stock
0.0000
Common Stock
2728.0000
2728.0000
D
Phantom Stock
0.0000
Common Stock
7500.0000
7500.0000
D
Stock Option (Right to Buy Common Stock)
2.8500
2028-02-16
Common Stock
8000.0000
8000.0000
D
Phantom Stock
0.0000
Common Stock
2679.0000
2679.0000
D
Phantom Stock
0.0000
Common Stock
3125.0000
3125.0000
D
Phantom Stock
0.0000
Common Stock
4167.0000
4167.0000
D
Stock Option (Right to Buy Common Stock)
11.2000
2027-02-21
Common Stock
8000.0000
8000.0000
D
Phantom Stock
0.0000
Common Stock
695.0000
695.0000
D
Phantom Stock
0.0000
Common Stock
829.0000
829.0000
D
Stock Option (Right to Buy Common Stock)
15.1500
2025-08-11
Common Stock
10000.0000
10000.0000
D
Phantom Stock
0.0000
Common Stock
283.0000
283.0000
D
Stock Option (Right to Buy Common Stock)
9.5500
2026-02-21
Common Stock
19000.0000
19000.0000
D
Phantom Stock
0.0000
Common Stock
767.0000
767.0000
D
Phantom Stock
0.0000
Common Stock
554.0000
554.0000
D
Phantom Stock
0.0000
Common Stock
867.0000
867.0000
D
Phantom Stock
0.0000
Common Stock
3062.0000
3062.0000
D
Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
These options were granted on 01/10/2019. These options are fully vested.
These options were granted on 02/16/2018. These options are fully vested.
These options were granted on 02/21/2017. These options are fully vested.
These options were granted on 08/12/2015. These options are fully vested.
These options were granted on 02/21/2016. These options are fully vested.
The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.
/s/ Janet Dillione
2020-05-18